News-Medical covers a scoping review suggesting the drugs may help androgen levels and menstrual cycles in PCOS, on top of their known metabolic effects.
Recap by typeshit. Full story at News-Medical.
A physio fielding years of peptide questions says strong studies are lacking, while noting that a lack of evidence doesn't prove they fail.
Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Nippard puts the two approved drugs on top for supervised weight loss and holds retatrutide at B-tier until it is approved.
Bloomberg traces how Amgen used genetic data from Iceland to guide its obesity drug research.
A look at peptide therapy pitched for healing and longevity, and how the recent US policy change could ripple into India.
Caliway Biopharmaceuticals developed CBL-514 to target abdominal fat cells, and researchers say it does more than shrink them. Details on how it works are at the link.
Loading…